Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US. The FDA sent the Danish ...

There was also some evidence that the use of discreet devices, like those of the NovoPen ® family, facilitates adherence to intensive insulin therapy regimens, helps to improve lifestyle ...

The hormone insulin plays a key role in the development of ... Discovery of Rare Gene Variants Provides Window Into Tailored Type 2 Diabetes Treatment Feb. 26, 2025 — A new study details the ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...